MOBIX LABS Registers 12.9M Shares for Resale, Faces Going Concern Doubt

TL;DR

**MOBXW is dumping shares, and with 'going concern' doubts, this looks like a race to the bottom.**

AI Summary

MOBIX LABS, INC. (MOBXW) filed an S-1/A on October 10, 2025, registering up to 12,890,274 shares of Class A Common Stock for resale by Selling Stockholders. This includes 1,030,000 shares from a $550,000 secured convertible promissory note and commitment shares, 1,693,750 shares from a $600,000 loan, 1,552,770 shares from a $1.0 million warrant exercise, 8,229,701 shares from a September 3, 2025 warrant inducement offer, and 384,053 shares for a financial advisor. The company will not receive proceeds from these sales, but could receive approximately $9.8 million if warrants are exercised for cash. The 12,890,274 shares represent approximately 18% of outstanding Class A Common Stock as of September 4, 2025. MOBIX LABS is an 'emerging growth company' and 'smaller reporting company' and faces risks including being an early-stage company, historical losses, and substantial doubt about its ability to continue as a going concern.

Why It Matters

This S-1/A filing signals a significant potential dilution event for MOBIX LABS investors, as the resale of 12,890,274 shares, representing 18% of outstanding Class A Common Stock, could depress the stock price. The company's reliance on warrant exercises for potential cash proceeds of $9.8 million is speculative, as there's no guarantee warrants will be exercised. For employees and customers, the 'going concern' risk highlights operational instability, while competitors might see an opportunity to capitalize on MOBIX LABS' financial vulnerabilities and market uncertainty.

Risk Assessment

Risk Level: high — The filing explicitly states 'there is substantial doubt about our ability to continue as a going concern,' indicating severe financial instability. Furthermore, the registration of 12,890,274 shares for resale, representing approximately 18% of outstanding Class A Common Stock, poses a significant dilution risk and could lead to a 'significant decline in the public trading price' of MOBXW.

Analyst Insight

Investors should exercise extreme caution and consider divesting MOBXW shares due to the high risk of dilution from the 12,890,274 shares registered for resale and the explicit 'going concern' warning. New investors should avoid MOBXW until the company demonstrates a clear path to profitability and resolves its financial stability issues.

Key Numbers

• 12,890,274 — Shares of Class A Common Stock (Registered for resale by Selling Stockholders, representing 18% of outstanding shares.)
• $9.8 million — Potential Gross Proceeds (From cash exercise of warrants, though not guaranteed.)
• $0.935 — Class A Common Stock Price (Last sale price on Nasdaq as of October 3, 2025.)
• $0.14 — Public Warrants Price (Last sale price on Nasdaq as of October 3, 2025.)
• $550,000 — Secured Convertible Promissory Note (Associated with 880,000 shares issuable upon conversion.)
• $600,000 — Loan Proceeds (Associated with 1,693,750 shares issued as collateral and commitment shares.)
• $1.0 million — Warrant Proceeds (Associated with 1,552,770 shares issuable upon exercise.)

Key Players & Entities

• MOBIX LABS, INC. (company) — Registrant
• Keyvan Samini (person) — President and Chief Financial Officer
• Greenberg Traurig, LLP (company) — Legal Counsel
• Nasdaq Stock Market LLC (regulator) — Stock Exchange
• $550,000 (dollar_amount) — Secured convertible promissory note
• $600,000 (dollar_amount) — Loan proceeds
• $1.0 million (dollar_amount) — Warrant proceeds
• $9.8 million (dollar_amount) — Potential cash from warrant exercises
• 12,890,274 (dollar_amount) — Shares of Class A Common Stock registered for resale
• 18% (dollar_amount) — Percentage of outstanding Class A Common Stock represented by resale shares

FAQ

Risk Factors

• Substantial Doubt About Going Concern [high — financial]: The company has a history of net losses and negative cash flows from operations, raising substantial doubt about its ability to continue as a going concern. This is a significant concern for investors as it indicates potential financial instability.
• Dependence on Future Financing [high — financial]: The company's ability to fund its operations and growth initiatives is dependent on its ability to secure additional financing. Failure to obtain necessary funding could materially and adversely affect its business, financial condition, and results of operations.
• Early-Stage Company Risks [medium — operational]: As an early-stage company, Mobix Labs faces numerous risks including unproven business models, limited operating history, and potential difficulties in scaling operations. These factors can lead to unpredictable financial performance.
• Competition [medium — market]: The company operates in a highly competitive market. Intense competition could lead to price pressures, reduced market share, and hinder its ability to achieve profitability.

Industry Context

Mobix Labs operates in a dynamic technology sector, likely involving semiconductors, connectivity solutions, or related hardware. This industry is characterized by rapid innovation, intense global competition, and significant capital expenditure requirements for research and development and manufacturing. Companies in this space often face cyclical demand and pressure to constantly evolve their product offerings to meet market needs.

Regulatory Implications

As a publicly traded company, Mobix Labs is subject to SEC regulations and reporting requirements. Its status as an 'emerging growth company' and 'smaller reporting company' allows for scaled-down disclosures, which may reduce the burden of compliance but also limit the transparency for investors compared to larger, more established companies.

What Investors Should Do

1. Monitor Warrant Exercise Activity
2. Evaluate Going Concern Risk
3. Analyze Selling Stockholder Behavior
4. Scrutinize Future Financing Needs

Key Dates

• 2025-10-10: S-1/A Filing — Registered up to 12,890,274 shares of Class A Common Stock for resale by Selling Stockholders, indicating potential dilution and a large number of shares becoming available in the market.
• 2025-09-03: Warrant Inducement Offer — This offer resulted in 8,229,701 shares being registered for resale, suggesting a significant number of warrants were exercised or are expected to be exercised, potentially impacting share count and ownership.

Glossary

Emerging Growth Company

A company with less than $1.235 billion in revenue during its most recently completed fiscal year that can take advantage of specified reduced reporting and other requirements applicable to public companies. (Mobix Labs qualifies for this status, meaning it has fewer disclosure obligations, which could make it harder for investors to get a complete picture of executive compensation.)

Smaller Reporting Company

A company that meets certain criteria related to public float and revenue, allowing for scaled-down disclosure requirements. (This designation, along with 'emerging growth company,' indicates Mobix Labs has reduced reporting burdens, potentially limiting the depth of financial and operational information available to investors.)

Selling Stockholders

Existing shareholders who are offering to sell their shares of the company's stock in the public market. (The S-1/A filing is primarily for the resale of shares by these stockholders, meaning the company itself will not receive proceeds from these sales, but the market will see increased supply of shares.)

Class A Common Stock

A class of common stock issued by the company, which is being registered for resale in this filing. (The resale of these shares directly impacts the supply and potential price of the company's Class A Common Stock on the market.)

Warrants

Securities that give the holder the right, but not the obligation, to purchase shares of the company's stock at a specified price (exercise price) before a certain expiration date. (The filing registers shares issuable upon the exercise of warrants, and the company could receive up to $9.8 million if these warrants are exercised for cash, which is a potential source of funding.)

Secured Convertible Promissory Note

A debt instrument that can be converted into equity (shares of stock) under certain conditions and is backed by collateral. (A $550,000 note is associated with shares registered for resale, indicating a past financing arrangement that may convert to equity, potentially increasing the number of outstanding shares.)

Year-Over-Year Comparison

This S-1/A filing primarily addresses the resale of shares by existing stockholders and does not appear to be a direct comparison to a prior period's financial performance filing. However, the registration of a large number of shares (12,890,274) suggests a significant increase in potential float compared to previous disclosures, likely stemming from various financing and warrant-related activities. New risks related to the going concern status and the volume of shares available for resale are prominent in this filing.

Key Financial Figures

• $0.00001 — on stock of Mobix Labs, Inc., par value $0.00001 per share (the "Class A Common Stock"),
• $550,000 — rtible promissory note in the amount of $550,000, and (b) up to 150,000 commitment share
• $600,000 — th a loan for proceeds of approximately $600,000 comprised of (a) 193,750 total commitme
• $1.0 million — tor for gross proceeds of approximately $1.0 million; Up to 8,229,701 shares issuable upon
• $9.8 million — n gross proceeds to us of approximately $9.8 million. However, we cannot predict when and in
• $0.935 — Common Stock as reported on Nasdaq was $0.935 per share and the last sale price of th
• $0.14 — blic Warrants as reported on Nasdaq was $0.14 per Public Warrant. We are an "emergi
• $1.235 billion — G COMPANY As a company with less than $1.235 billion in revenue during its most recently com
• $1.235 b — which our annual gross revenues exceed $1.235 billion, (b) the date that we become a "l
• $1.0 billion — date on which we have issued more than $1.0 billion in nonconvertible debt during the prece
• $250 million — ock held by non-affiliates is less than $250 million measured on the last business day of ou
• $100 million — or (ii) our annual revenue is less than $100 million during the most recently completed fisc
• $700 million — ock held by non-affiliates is less than $700 million measured on the last business day of ou
• $1.00 m — daq listing requirements, including the $1.00 minimum bid price requirement and to rema

Filing Documents

• forms-1a.htm (S-1/A) — 6444KB
• ex4-15.htm (EX-4.15) — 104KB
• ex5-1.htm (EX-5.1) — 17KB
• ex10-48.htm (EX-10.48) — 147KB
• ex10-49.htm (EX-10.49) — 266KB
• ex10-50.htm (EX-10.50) — 345KB
• ex10-51.htm (EX-10.51) — 87KB
• ex10-52.htm (EX-10.52) — 76KB
• ex10-53.htm (EX-10.53) — 26KB
• ex23-1.htm (EX-23.1) — 4KB
• ex23-2.htm (EX-23.2) — 4KB
• ex107.htm (EX-FILING FEES) — 25KB
• forms-1_001.jpg (GRAPHIC) — 5KB
• ex5-1_001.jpg (GRAPHIC) — 3KB
• ex10-50_001.jpg (GRAPHIC) — 9KB
• 0001493152-25-017858.txt ( ) — 23301KB
• mobx-20250630.xsd (EX-101.SCH) — 98KB
• mobx-20250630_cal.xml (EX-101.CAL) — 104KB
• mobx-20250630_def.xml (EX-101.DEF) — 555KB
• mobx-20250630_lab.xml (EX-101.LAB) — 776KB
• mobx-20250630_pre.xml (EX-101.PRE) — 676KB
• forms-1a_htm.xml (XML) — 4499KB
• ex107_htm.xml (XML) — 8KB

USE OF PROCEEDS

USE OF PROCEEDS 25 MARKET PRICE OF THE CLASS A COMMON STOCK AND DIVIDENDS 26 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS 27

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF MOBIX LABS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF MOBIX LABS 29

BUSINESS

BUSINESS 49 MANAGEMENT 59 EXECUTIVE AND DIRECTOR COMPENSATION 65

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 71 SECURITIES ACT RESTRICTIONS ON RESALE OF SECURITIES 83

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 84 SELLING STOCKHOLDERS 86 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 87 PLAN OF DISTRIBUTION 92 LEGAL MATTERS 93 EXPERTS 93 WHERE YOU CAN FIND ADDITIONAL INFORMATION 93 INDEX TO FINANCIAL STATEMENTS F-1 ABOUT THIS PROSPECTUS This prospectus relates to the resale by the Selling Stockholders identified in this prospectus under the caption "Selling Stockholders," from time to time, of up to an aggregate of 12,890,274 shares of Class A Common Stock. We are not selling any shares of Class A Common Stock under this prospectus, and we will not receive any proceeds from the sale of shares of Class A Common Stock offered hereby by the Selling Stockholders, although we may receive cash from the exercise of the Warrants. You should rely only on the information provided in this prospectus. We have not authorized anyone to provide you with any other information, and we take no responsibility for, and can provide no assurances as to the reliability of, any other information that others may give you. The information contained in this prospectus speaks only as of the date set forth on the cover page and may not reflect subsequent changes in our business, financial condition, results of operations and prospects. We are not, and the Selling Stockholders are not, making offers to sell these securities in any jurisdiction in which an offer or solicitation is not authorized or permitted or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such an offer or solicitation. You should read this prospectus in its entirety before making an investment decision. You should also read and consider the information in the documents to which we have referred you in the sections entitled "Where You Can Find More Information." Unless otherwise indicated or the context otherwise requires, all references to "Mobix," "Company," "R

View Full Filing

View this S-1/A filing on SEC EDGAR